The society of thoracic surgeons: 30-day operative mortality and morbidity risk models

Shroyer, A. Laurie; Coombs, Laura P.; Peterson, Eric D.; Eiken, M; DeLong, Elizabeth R.; Chen, Anita; Ferguson, T. Bruce; Grover, Frederick L.; Edwards, Fred H.

doi:10.1016/s0003-4975(03)00179-6

Cited by 572 publications

(367 citation statements)

References 13 publications

Supporting

Mentioning

337

Contrasting

Unclassified

Order By: Relevance

“…The predictive power of postoperative stroke, prolonged ventilation and renal failure was lower than that of mortality. Shroyer et al (8) assessed the STS mortality and morbidity risk models, and reported that the reliability of the STS risk algorithm on the prediction of morbidities needs further assessment.…”

Section: Discussionmentioning

confidence: 99%

“…The accuracy and discriminatory ability of the STS and EuroSCORE risk algorithms have been compared and validated with other statistical models (3)(4)(5)(6). They have been applied to predict early mortality after coronary artery bypass graft (CABG) surgery in the United Kingdom, the United States of America and Sweden (2,(6)(7)(8). These models have been shown to be a good predictor of early mortality after CABG surgery in these countries.…”

mentioning

confidence: 99%

See 1 more Smart Citation

Early mortality from off-pump and on-pump coronary bypass surgery in Canada: A comparison of the STS and the EuroSCORE risk prediction algorithms

Farrokhyar

Wang

Kent

et al. 2007

Canadian Journal of Cardiology

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

mentioning

confidence: 99%

Early mortality from off-pump and on-pump coronary bypass surgery in Canada: A comparison of the STS and the EuroSCORE risk prediction algorithms

Farrokhyar

Wang

Kent

et al. 2007

Canadian Journal of Cardiology

View full text Add to dashboard Cite

“…The PARTNER I was the first large randomized trial conducted using a balloonexpandable device (Edwards Sapien Valve) to test the effectiveness of TAVI and the publication of its 1-year outcomes has really redefined the conventional wisdom [8,20] . Patients were divided into two groups: the first one with patients who were considered available for surgery although a high surgical risk (Cohort A, n = 699, STS risk score > 10% or a predicted risk of death by 30 days after surgery of 15% or higher derived from other comorbidities), and the second one (Cohort B, n = 358) with patients who have a real contraindication for surgery because of coexisting conditions that would be associated with a predicted probability of 50% or more of either death by 30 days after surgery or a serious irreversible condition [21] . In the Cohort A, patients undergoing TAVI showed similar 1-year all-cause mortality rate compared with SAVR group (24.2% vs. 26.8%; P = 0.001 for non-inferiority) [11] .…”

Section: High-risk Patientsmentioning

confidence: 99%

Who is the next for aortic valve implantation? Present and future indications

Verolino¹,

Veneri²,

Carpenito³

et al. 2018

View full text Add to dashboard Cite

Aortic valve stenosis (AS) represents the most prevalent valvular defect worldwide. It is a progressive disease with a long latency interval and a poor prognosis after symptoms present. According to current European Society of Cardiology guidelines, transcatheter aortic valve implantation (TAVI) is recommended in all patients with severe symptomatic AS and a predicted survival longer than one year, who are not suitable for surgical valve replacement. Despite these recommendations, several studies over the past few years suggest extending these indications towards lower risk AS populations. Otherwise, current available operative risk scores such as Society of Thoracic Surgeons score and EuroSCORE, may offer an incomplete risk assessment; in this setting, the Heart Team plays a crucial role in defining the most appropriate therapeutic strategy in patients with AS. In this review, we aim to discuss the current and future indications for TAVI, analyzing available literature according to patients' profile risk (high/mid/low risk) and other specific conditions (valve-in-valve, bicuspid valve and pure aortic regurgitation).

show abstract

“…However, some of the medical/ surgical specialities, such as cardiothoracic surgery, have established national databases which allow countrywide data to be extracted for clinical audits (7)(8)(9)(10). One of these databases in the field of cardiothoracic surgery was established in South Africa, with the expressed aim of being both a resource for answering either specific research questions among a series of patients, or to enable prospective recording of data from a range of patients treated by the speciality, which could be used later in either clinical or healthcare systems research (9).…”

Section: Introductionmentioning

confidence: 99%

A 10 years audit of cardiothoracic referrals from a pulmonology service in a developing country: impact of patient human immunodeficiency virus status

Nyale

Patel

Feldman³

2016

Ann. Transl. Med.

View full text Add to dashboard Cite

Background: There are few studies that have documented the clinical presentation, complication rate and outcome of cardiothoracic referrals from a Pulmonology Service, particularly in developing countries. Furthermore, the impact of human immunodeficiency virus (HIV) status on such referrals and their outcomes is not well documented.Methods: This was a retrospective audit of combined pulmonologist/cardiothoracic consultations, undertaken among the tertiary academic hospitals attached to the University of the Witwatersrand, Johannesburg, South Africa, over a 10 years period (2001)(2002)(2003)(2004)(2005)(2006)(2007)(2008)(2009)(2010) in order to document the clinical features of these referrals and to determine any impact of HIV status on trends in disease presentations, complications and outcome.Results: A total of 847 patients were evaluated on whom a variety of surgical procedures was performed, 50.4% being therapeutic, 32.8% diagnostic and 16.9% both therapeutic and diagnostic. HIV status was known in 488 cases.Of these 229 (46.9%) were HIV-seropositive and 259 (53.1%) -seronegative. The main reasons for referral were for infective conditions, including tuberculosis (TB), pleural disease/effusion/empyema, and other bacterial infections, with significantly more of the TB patients being HIV-seropositive (P<0.0001).There was a trend for increasing presentations for TB and pleural conditions, particularly during the last 4-5 years of the audit, coinciding with an increase in the numbers of HIV-positive referrals. HIV status had no impact on the frequency of surgical complications or mortality. Conclusions:The audit indicates an increasing referral rate of HIV-seropositive patients to cardiothoracic services in Johannesburg, particularly in association with TB and pleural diseases. However with careful cardiothoracic/pulmonologist evaluation of the cases the frequency of complications and mortality appear to be no different from that of HIV-seronegative cases.

show abstract

The society of thoracic surgeons: 30-day operative mortality and morbidity risk models

Cited by 572 publications

References 13 publications

Early mortality from off-pump and on-pump coronary bypass surgery in Canada: A comparison of the STS and the EuroSCORE risk prediction algorithms

Early mortality from off-pump and on-pump coronary bypass surgery in Canada: A comparison of the STS and the EuroSCORE risk prediction algorithms

Who is the next for aortic valve implantation? Present and future indications

A 10 years audit of cardiothoracic referrals from a pulmonology service in a developing country: impact of patient human immunodeficiency virus status

Contact Info

Product

Resources

About